The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid β fibril formation

Point mutations in the amyloid precursor protein gene ( ) cause familial Alzheimer's disease (AD) by increasing generation or altering conformation of amyloid β (Aβ). Here, we describe the mutation (Δ690-695), the first reported deletion causing autosomal dominant AD. Affected individuals have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science translational medicine 2021-08, Vol.13 (606), p.1
Hauptverfasser: Pagnon de la Vega, María, Giedraitis, Vilmantas, Michno, Wojciech, Kilander, Lena, Güner, Gökhan, Zielinski, Mara, Löwenmark, Malin, Brundin, RoseMarie, Danfors, Torsten, Söderberg, Linda, Alafuzoff, Irina, Nilsson, Lars N G, Erlandsson, Anna, Willbold, Dieter, Müller, Stephan A, Schröder, Gunnar F, Hanrieder, Jörg, Lichtenthaler, Stefan F, Lannfelt, Lars, Sehlin, Dag, Ingelsson, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Point mutations in the amyloid precursor protein gene ( ) cause familial Alzheimer's disease (AD) by increasing generation or altering conformation of amyloid β (Aβ). Here, we describe the mutation (Δ690-695), the first reported deletion causing autosomal dominant AD. Affected individuals have an age at symptom onset in their early forties and suffer from a rapidly progressing disease course. Symptoms and biomarkers are typical of AD, with the exception of normal cerebrospinal fluid (CSF) Aβ42 and only slightly pathological amyloid-positron emission tomography signals. Mass spectrometry and Western blot analyses of patient CSF and media from experimental cell cultures indicate that the mutation alters APP processing by increasing β-secretase cleavage and affecting α-secretase cleavage. Furthermore, in vitro aggregation studies and analyses of patient brain tissue samples indicate that the longer form of mutated Aβ, AβUpp1-42 , accelerates the formation of fibrils with unique polymorphs and their deposition into amyloid plaques in the affected brain.
ISSN:1946-6234
1946-6242
1946-6242
1946-3242
DOI:10.1126/scitranslmed.abc6184